In a report released today, David Amsellem from Piper Sandler reiterated a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a price target of $30.00. The company’s shares ...

Armed with positive data from a phase 2b trial, Teva and Sanofi have decided to push their anti-TL1A antibody duvakitug into a phase 3 programme in inflammatory bowel disease (IBD). The results of ...

This feature is currently unavailable; we are sorry for the inconvenience to you. Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets.

1 Day TEVA -0.50% DJIA -0.32% S&P 500 -0.29% Health Care/Life Sciences -0.52% ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Teva's long haul to a turnaround of its business has been dealt a blow by the FDA, which has just declined to approve the company's long-acting formulation of schizophrenia drug risperidone.

After hours: 7:57:48 p.m. EST ...

Første sæson af Severance markerede sig i 2022 som en af de mest originale, fascinerende og underholdende serier i lang tid. Man følger Mark Scout, der hver dag møder ind på mystiske Lumon Industries ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...